Panel: All adults should get whooping cough shots

February 22, 2012 By MIKE STOBBE , AP Medical Writer

A federal advisory panel wants all U.S. adults to get vaccinated against whooping cough.

The panel voted Wednesday to expand its recommendation to include all those 65 and older who haven't gotten a whooping cough shot as an adult.

Children have been vaccinated against whooping cough since the 1940s, but a vaccine for adolescents and adults was not licensed until 2005.

Since then, the Advisory Committee on Immunization Practices has gradually added groups of adults to its recommendations, including 2010 advice that it be given to elderly people who spend a lot of time around infants.

Wednesday's recommendation means now all adults should get at least one dose.

"They've been moving up to this in ," said Dr. William Schaffner, a Vanderbilt University vaccines expert.

Whooping cough, or , is a highly contagious that in rare cases can be fatal. It leads to severe coughing that causes children to make a distinctive whooping sound as they gasp for breath.

Recommendations from the panel are usually adopted by the government, which sends the guidance out to doctors.

Contributing to the push to vaccinate more adults was a California whooping cough epidemic in 2010 that infected 9,000. Ten babies died after exposure to infected adults or older children.

There's little data on how many elderly people have gotten the vaccine. Only about 8 percent of adults under 65 have been vaccinated, but about 70 percent of adolescents have.

believe whooping cough is underreported in , perhaps because in older people the illness can be hard to distinguish from other coughing ailments.

A goal of the recommendation is to prevent teens and adults from spreading the disease to infants, although there's not good evidence this "herd immunity" approach has worked so far. Vaccination for children is included in a series of shots, beginning at 2 months.

The adult vaccine combines protection against tetanus, and whooping cough. One version of the vaccine, made by GlaxoSmithKline, was licensed for use in the elderly last year. The committee said another version, made by Sanofi Pasteur, can also be given. Both cost about $35 a dose.

The shot is as safe as a regular tetanus booster. Estimates range widely for how effective the vaccine is at preventing in older adults, or how much its protection wanes years afterward.

Explore further: Study: Whooping cough vaccination fades in 3 years (Update)

More information: CDC: http://www.cdc.gov/vaccines/recs/ACIP/

shares

Related Stories

Study: Whooping cough vaccination fades in 3 years (Update)

September 19, 2011

The whooping cough vaccine given to babies and toddlers loses much of its effectiveness after just three years - a lot faster than doctors believed - and that could help explain a recent series of outbreaks in the U.S. among ...

Recommended for you

Big Data can save lives, says leading cancer expert

May 16, 2016

The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.

New soap to ward off malaria carrying mosquitoes

May 13, 2016

(Medical Xpress)—Gérard Niyondiko along with colleagues Frank Langevin and Lisa Barutel has posted a project on the crowd source funding site ulule for a product called Faso Soap. They claim the soap can cut in half the ...

Smartphones uncover how the world sleeps

May 6, 2016

A pioneering study of worldwide sleep patterns combines math modeling, mobile apps and big data to parse the roles society and biology each play in setting sleep schedules.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.